According to several studies, BRAF mutations are associated with poor prognostic factors, including larger tumor size, older age, male gender, extrathyroidal extension, tumor multifocality, lymph node metastasis, advanced tumor stage, and recurrence [5–9]. The gene discussed is BRAF; the disease is neoplasm.